🛎️SOPHiA GENETICS successfully lists on Nasdaq🛎️
Portfolio
27 July 2021
Data-driven medicine leader SOPHiA GENETICS announces the closing of its $234 Million Initial Public Offering and $20 Million Private Placement (ticker: SOPH).
Sophia Genetics offers a cloud-based Software-as-a-Service platform — the SOPHiA DDM™ platform — that enables healthcare institutions to get quick, robust insights from their data. The technology is applied to diseases such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support discoveries, treatment decisions, and drug development efforts. Today, over 780 medical institutions in 70 countries use the Sophia Genetics solutions.
Read the full press release.
Take a look at the bell ringing ceremony here.